highly differentiated algorithms measuring existing and previously inaccessible biomarkers at scale, with high precision
|
|
|
|
brain region analysis for a given image, to measure brain volume both cross-sectionally and longitudinally.
|
|
|
|
|
CONSISTENT |
delivering advanced clinical endpoints while reducing variability by automating traceability and consistent reproducibility into every dataset, all underpinned by a highly granular audit trial. |
COMPATIBLE |
reduces data upload, management and analysis burden for sites, sponsors and readers through seamless integration with existing workflows without the need for additional software or tools. |
FLEXIBLE |
capabilities in all clinical trial phases, including patient stratification and exploratory endpoints, as well as use for post-market assessment and clinical diagnostics. |
BESPOKE |
distinct technologies and scientific expertise to meet specific neurological disease needs with the required specialism and complex understanding of each different indication. |